arrow
E

Erik Duijvelaar

department of pulmonary medicine
H指数:7
被引数:276

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial
2023-06-088
OAAI
Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19

伊马替尼从癌症到新型冠状病毒肺炎的最佳药物再利用的药代动力学和药效学

2023-05-012
OA
The efficacy and safety of intravenous imatinib in invasively ventilated patients with COVID-19 related acute respiratory distress syndrome (InventCOVID): a multicentre, randomised, doubleblinded, placebo-controlled, phase II clinical study
2022-12-011
PRE
Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19
2021-11-250
PRE
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial
2021-09-01168
OAAI
Imatinib in patients with severe COVID-19: a randomised, doubleblind, placebo-controlled, clinical trial (vol 9, pg 957, 2021)
2021-08-010
OAAI